BDBM50006844 (S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-1-cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexylcarbamoyl)-ethyl]-2-(morpholine-4-sulfonylamino)-3-phenyl-propionamide::(S)-N-{(1S,2S)-2-(2-Amino-thiazol-4-yl)-1-[1-((S)-cyclohexylmethyl)-2,3-dihydroxy-5-methyl-hexylcarbamoyl]-ethyl}-2-((R)-morpholine-4-sulfonylamino)-3-phenyl-propionamide::CHEMBL34894::CI-992::N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexylcarbamoyl)-ethyl]-2-(morpholine-4-sulfonylamino)-3-phenyl-propionamide

SMILES CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1csc(N)n1)NC(=O)[C@H](Cc1ccccc1)NS(=O)(=O)N1CCOCC1

InChI Key InChIKey=QGJKHQRFJGLJLV-VFFRCKCKSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50006844   

TargetPepsin A-5(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  2.02E+5nMAssay Description:Inhibitory activity against pepsin.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  0.570nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  0.360nMAssay Description:In vitro inhibitory activity against monkey plasma reninMore data for this Ligand-Target Pair
In DepthDetails Article
TargetRenin(Rattus norvegicus)
TBA

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  0.320nMAssay Description:Inhibitory activity of the compound against renin was determinedMore data for this Ligand-Target Pair
In DepthDetails Article
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  0.370nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in monkeyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Rattus norvegicus)
TBA

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  199nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  0.360nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  2nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in monkeyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Bos taurus)
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844((S)-N-[(S)-2-(2-Amino-thiazol-4-yl)-1-((1S,2R,3S)-...)
Affinity DataIC50:  1.25E+3nMAssay Description:Inhibition of Bovine Cathepsin DMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed